Mesenchymal stem-cell therapy in a regulated environment

Cytotherapy

Volumn 3, Issue 5, 2001, Pages 397-398

  Gee, Adrian ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; CELL CULTURE; CLINICAL PROTOCOL; CONFERENCE PAPER; CONTAMINATION; FOOD AND DRUG ADMINISTRATION; GENE THERAPY; GOOD MANUFACTURING PRACTICE; HEALTH CARE POLICY; HUMAN; IMMUNOPHENOTYPING; LAW; LEGAL ASPECT; MESENCHYME CELL; QUALITY CONTROL; SAFETY; SOMATIC CELL; THAWING; BIOLOGICAL THERAPY; CULTURE TECHNIQUE; CYTOLOGY; MESODERM; REVIEW; STANDARD; STEM CELL; TRANSPLANTATION; UNITED STATES;

CULTURE TECHNIQUES; HUMANS; MESODERM; STEM CELLS; TISSUE THERAPY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0035527590     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/146532401753277391     Document Type: Conference Paper

References (8)

1. Mesenchymal stem cells: Biology and potential clinical uses
2. Warning letter from CBER to the Institute of Gene Therapy University of Pennsylvania GLP 7/3/2000
3. Application of Current Statutory Authorities to Human Somatic Cell Therapy Products and Gene Therapy Products
4. Current good manufacturing practice for blood and blood components
5. Proposed approach to regulation of cellular and tissue-based products
6. Current good tissue practice for manufacturers of human cellular and tissue-based products; Inspection and enforcement; Proposed rule
7. Human cells, tissues and cellular and tissue-based products; Establishment registration and listing
8. Suitability determination for donors of human cellular and tissue based products